AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $16.78B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| PME | PME signs A$53M, 7-year contract with BayCare | PRICE SENSITIVE | 04/02/25 | |
| PME | On market share buy-back | 22/03/18 | ||
| PME | Change of Director's Interest Notice - Sam Hupert | 20/03/18 | ||
| PME | PME Cleansing Notice - Co-founders sell down | 20/03/18 | ||
| PME | Change of Director's Interest Notice - Anthony Hall | 20/03/18 | ||
| PME | Appendix 3B - Exercise of share options | 14/03/18 | ||
| PME | S&P DJ Indices Announces March Quarterly Rebalance | PRICE SENSITIVE | 09/03/18 | |
| PME | HY2018 Investor Presentation - Mar 2018 | 05/03/18 | ||
| PME PME signs A$53M, 7-year contract with BayCare | |||
| 04/02/25 | PRICE SENSITIVE | ||
| PME On market share buy-back | |||
| 22/03/18 | |||
| PME Change of Director's Interest Notice - Sam Hupert | |||
| 20/03/18 | |||
| PME PME Cleansing Notice - Co-founders sell down | |||
| 20/03/18 | |||
| PME Change of Director's Interest Notice - Anthony Hall | |||
| 20/03/18 | |||
| PME Appendix 3B - Exercise of share options | |||
| 14/03/18 | |||
| PME S&P DJ Indices Announces March Quarterly Rebalance | |||
| 09/03/18 | PRICE SENSITIVE | ||
| PME HY2018 Investor Presentation - Mar 2018 | |||
| 05/03/18 | |||
